期刊文献+

PPARγ上调对PCOS患者卵巢颗粒细胞P450arom mRNA的表达及T转化效应的影响 被引量:5

Effects of up-regulation of PPARγ on expression of P450arom mRNA and T transforming effects in ovarian granulosa cells from patients with PCOS
下载PDF
导出
摘要 目的:探讨PPARγ上调对PCOS患者卵巢颗粒细胞P450arom mRNA表达的调控作用及对T转化效应的影响。方法:提取10例雄激素正常的PCOS患者(NA-PCOS组)、10例伴高雄激素血症的PCOS患者(HA-PCOS组)及10例仅因输卵管因素不孕患者(对照组)的卵巢颗粒细胞,分别给予0、1、10 nmol/L的PPARγ激动剂罗格列酮培养48 h后,采用RT-PCR测定PPARγ、P450arom mRNA的表达,采用ELISA法测定培养液中E2值,计算T转化率。结果:PPARγ上调后,3组患者P450arom mRNA的表达均降低,T转化率下降,尤其是HA-PCOS组(P<0.05)。PPARγ上调(10 nmol/L罗格列酮处理)后,HA-PCOS组卵巢颗粒细胞中PPARγmRNA的表达水平和T转化率负相关,P450arom mRNA的表达水平和T转化率正相关(r=-0.633、0.829,P<0.05)。结论:PPARγ可能通过抑制P450arom参与PCOS高雄激素血症的发生。 Aim:To explore the effects of up-regulation of PPARγon expression of P450arom mRNA and T transfor-ming effects in the ovarian granulosa cells from patients with polycystic ovarian syndrome ( PCOS) .Methods:A total of 30 patients were included, with 10 in NA-PCOS group(PCOS with normal androgen),10 in HA-PCOS group(PCOS with hy-perandrogenism) and 10 in control group.Granulosa cells were prepared and treated with 0,1,10 nmol/L rosiglitazone for 48 h.The expressions of PPARγmRNA and P450arom mRNA were measured by RT-PCR.After intervention, the E2 value in broth was determined by ELISA and T transforming rate was calculated .Results:After the up-regulation of PPARγ, the expression of P450arom mRNA and the T transforming rate in the 3 groups were decreased,especially in the HA-PCOS group.In HA-PCOS group(being treated by 10 nmol/L rosiglitazone),the expression of PPARγmRNA was negatively as-sociated with T transforming rate,and the expression of P450arom mRNA was positively associated with T transforming rate (r=-0.633,0.829,P〈0.05).Conclusion: PPARγmay participate in the pathogenesis of PCOS with high androgen level by down-regulating the expression of P450arom.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2015年第6期790-793,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关省部共建项目201201001
关键词 多囊卵巢综合征 卵巢颗粒细胞 过氧化物酶体增殖物激活受体Γ 细胞色素P450芳香化酶 T转化效应 polycystic ovarian syndrome ovarian granulosa cell peroxisome proliferator activated receptor γ cyto-chrome P450 aromatase T transforming effect
  • 相关文献

参考文献14

二级参考文献57

  • 1陶红,米树华,陆召麟.青春期多囊卵巢综合征肾上腺雄激素合成与胰岛素抵抗的关系[J].中国糖尿病杂志,2006,14(3):162-165. 被引量:4
  • 2FRANCA F,DARIA P,VERONICA L,et al.Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels[J].Fertil Steril,2009,92(2):626-634. 被引量:1
  • 3ALLEMAND MC,TUMMON IS,PHY JL,et al.Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound[J].Fertil Steril,2006,85(1):214-219. 被引量:1
  • 4MADHAVI P,PERVIN M,JYOTSNA MB,et al.CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome[J].2009,92(2):653-659. 被引量:1
  • 5SULTAN C,PARIS F.Clinical expression of polycystic ovary syndrome in adolescent girls[J].Fertil Steril,2006,86(1):6. 被引量:1
  • 6BOULMAN N,LEVY Y,LEIBA R,et al.Increased C-reactive protein levels in the polycystic ovary syndrome:a marker of cardiovascular disease[J].J Clin Endocrinol Metab,2004,89:2160-2165. 被引量:1
  • 7CEMIL K,AYCAN FE,DINCXER C,et al.Advanced oxidation protein products are increased in women with polycystic ovary syndrome:relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome[J].Fertil Steril,2009,92(4):1372-1377. 被引量:1
  • 8TOULIS KA,GOULIS DG,KOLIBIANAKIS EM,et al.Risk of gestational diabetes mellitus in women with polycystic ovary syndrome:a systematic review and a meta-analysis[J].Fertil Steril,2009,92(2):667-677. 被引量:1
  • 9WEI HJ,YOUNG R,KUO IL,et al.Prevalence of insulin resistance and determination of risk factors for glucose intolerance in polycystic ovary syndrome:a cross-sectional study of Chinese infertility patients[J].Fertil Steril,2009,91(5):1864-1868. 被引量:1
  • 10Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of south eastern United States: a prospective study J]. J Clin Endocrinol Metab, 1998, 83 (9) : 3078 - 3082. 被引量:1

共引文献51

同被引文献58

  • 1赵君利,陈子江,石玉华,耿玲,马增香,李媛,唐蓉.育龄期妇女体毛状况调查及其在多囊卵巢综合征诊断中的初步应用[J].中华妇产科杂志,2007,42(9):590-594. 被引量:15
  • 2Jayasena CN, Franks S. The management of patients with polycystic ovary syndrome[J]. Nat Rev Endocrinol 2014, 10(10): 624-636. 被引量:1
  • 3Witchel SF. Non-classic congenital adrenal hyperplasia[J]. Steroids, 2013, 78(8): 747-7S0. 被引量:1
  • 4Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004, 81(1): 19-25. 被引量:1
  • 5Azziz R. The evaluation and management of hirsutism[J]. Obstet Gynecol, 2003, 101(S Pt 1): 995-1007. 被引量:1
  • 6Neocleous V, Ioannou YS, Bartsota M, et al. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyp erplasia [J ]. Clin Biochem, 2009, 42 ( 13-14): 1363-1367. 被引量:1
  • 7Tardy V, Menassa R, Snlmont V, et al. Phenotype-genotype correlations of 13 Rare CYP21A2 mutations detected in 46 patients affected with 21-Hydroxylase deficiency and in one carrier [J]. J Clin Endocrinol Metab, 2010, 95 (3): 1288 - 1300. 被引量:1
  • 8Escobar-Morreale HF, Sanch6n R, San Millin JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs[J]. J Clin Endocrinol Metab, 2008, 93(2): 527-533. 被引量:1
  • 9Admoni O, Israel S, Lavi I, et al. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype[J]. Clin Endocrinol (Oxf), 2006, 64(6): 645-651. 被引量:1
  • 10Bidet M, Bellanne-Chantelot C, Galand-Portier MB, et al. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members[J].J Clin Endocrinol Metab, 2009, 94(5): 1570-1578. 被引量:1

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部